2026 Alzheimer Association International Conference - Part 2
In part two of this series on the 2026 Alzheimer Association International Conference, Dr. Greg Cooper talks with Drs. Trey Bateman and Gregg Day about recent clinical trials, evolving treatment strat...
27 Aug 12min
2026 Alzheimer Association International Conference - Part 1
In part one of this series, Dr. Greg Cooper talks with Drs. Trey Bateman and Gregg Day about blood-based biomarkers, anti-amyloid therapies, and other highlights from the 2026 Alzheimer Association In...
24 Aug 16min
The Relationship Between Age and Recovery After Spinal Cord Injury
Dr. Shuvro Roy talks with Prof. Catherine Jutzeler about how age influences neurologic and functional recovery after spinal cord injury and how these findings could inform treatment and future clinica...
20 Aug 24min
Virtual vs In-Person Neurologic Ambulatory Care
Dr. Greg Cooper talks with Dr. Chloe Hill about comparing virtual and in-person neurology outpatient visits for new patients. Read the related article in Neurology®. Disclosures can be found at Neuro...
17 Aug 19min
American Epilepsy Society Clinical Practice Guideline
Dr. Dara Albert talks with Dr. Daniel Freedman about the new practice guideline from the American Epilepsy Society on infantile epilepsy, highlighting key findings on medication, dietary therapy, and ...
13 Aug 19min
Post-Traumatic Headache in Children and Genetic Risk of Migraine
Dr. Jessica Ailani talks with Dr. Serena Orr about the genetic risk of migraine and post-traumatic headache in children. Read the related article in Neurology®Genetics. Disclosures can be found at N...
10 Aug 16min
The Current State of Diagnostics for Neuroimmunologic Disorders in Africa
Dr. Paul Crane talks with Drs. Fiifi Duodu and Malya Sahu about neuroimmunology and multiple sclerosis diagnosis in Africa, including challenges and efforts to improve care. Read the related article ...
6 Aug 21min
Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA
Dr. Elizabeth Coon talks with Dr. Lucy Norcliffe-Kaufmann about the mechanism-based therapy with ampreloxetine for neurogenic orthostatic hypotension in multiple system atrophy, highlighting recent cl...
3 Aug 22min
